Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Class IDrug

0.9% Sodium Chloride Injection USP 500 mL recall

Summary

Baxter Healthcare Corporation is recalling 0.9% Sodium Chloride Injection USP 500 mL (drug). According to the FDA report, the reason is: Presence of particulate matter: Particulates identified as fiberglass. The FDA rated this a Class I: most serious: there is a reasonable chance the product could cause serious health problems or death. Recall status: Ongoing.

Understanding this recall

What happened

Baxter is recalling 0.9% Sodium Chloride Injection (500 mL VIAFLEX bags) because particles identified as fiberglass were found.

Why it matters

Medicines given by injection or IV go straight into the bloodstream, so they must be free of visible and sub-visible particles. Particles such as glass, metal or plastic in an injectable can, in principle, block small blood vessels or cause irritation, inflammation or clots. That risk is why the FDA treats particulate matter in injectables seriously.

Who should pay attention

Hospital, clinic and pharmacy staff who use 500 mL saline bags.
Distribution in the FDA report: Natonwide in the USA

How to check your product

Check the lot number and expiration date on the bag and case.
Codes listed by the FDA: Lot: Y495523, Y495523A, Exp 31-Oct-2027

Based only on the FDA enforcement record plus general public-health background on this type of hazard. Not medical advice; if you have symptoms or concerns, contact a doctor or pharmacist.

Details from the FDA report

Product
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
Reason
Presence of particulate matter: Particulates identified as fiberglass
Lot / code info
Lot: Y495523, Y495523A, Exp 31-Oct-2027
Quantity
145,464 500mL bags
Distribution
Natonwide in the USA
Recalling company
Baxter Healthcare Corporation, Deerfield, IL United States
Recall started
August 17, 2026
FDA report date
September 9, 2026
Classification
Class I: Most serious: there is a reasonable chance the product could cause serious health problems or death.
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number
D-0849-2026

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.